SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-116167
Filing Date
2022-11-09
Accepted
2022-11-09 06:57:14
Documents
14
Period of Report
2022-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2229832d2_8ka.htm   iXBRL 8-K/A 30069
2 EXHIBIT 99.1 tm2229832d2_ex99-1.htm EX-99.1 286427
6 GRAPHIC tm2229832d2_ex99-1img01.jpg GRAPHIC 10547
  Complete submission text file 0001104659-22-116167.txt   544678

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA egrx-20221107.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20221107_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20221107_pre.xml EX-101.PRE 22593
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2229832d2_8ka_htm.xml XML 4868
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36306 | Film No.: 221370590
SIC: 2834 Pharmaceutical Preparations